Ensuring that China’s 1.4 billion citizens are adequately fed continues to top the policy agenda. While the Asian giant ...

With the fate of the BIOSECURE Act currently in limbo, WuXi AppTec is looking on the brighter side for 2025. | With the fate ...

China’s DeepSeek shocked the world by delivering unexpected innovation at an unbelievable price. But this disruptive trend isn’t confined to Big Tech: It has been quietly happening in the ...

As of 12:57:42 PM EDT. Market Open. China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma", the "Company" or "We"), an NYSE American-listed corporation with a fully-integrated specialty ...

Jacobio Pharma (1167.HK) released its 2024 annual results, with revenue of RMB160 million, R&D expense of RMB330 million. Major operating and financing activities generated RMB320 million cash inflows ...

Bulk drug products or functional food such as vitamin Cs are highly ... CSPC successfully shaped itself into one of the leading pharmaceutical companies in China. One of the most recent ...

Liang said the US Food and Drug Administration (FDA ... Akeso’s new drug, which is not a generic, has been approved by China’s pharmaceutical regulator for some lung cancer patients.